Description:
NSABP Protocol C-09: Quality of Life Form Oxaliplatin and Capecitabine With or Without an Hepatic Arterial Infusion With Floxuridine in Treating Patients Who Are Undergoing Surgery and/or Ablation for Liver Metastases Due to Colorectal Cancer NCT00268463 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=FC7E0FCB-064A-58CD-E034-0003BA3F9857
Link:
https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=FC7E0FCB-064A-58CD-E034-0003BA3F9857Keywords:
Versions (5)
- 8/27/12 8/27/12 -
- 1/9/15 1/9/15 - Martin Dugas
- 3/21/15 3/21/15 - Martin Dugas
- 4/10/21 4/10/21 - Ahmed Rafee, MD
- 9/20/21 9/20/21 -
Copyright Holder:
folgtUploaded on:
September 20, 2021
DOI:
To request one please log in.License :
Creative Commons BY 4.0Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
All patients in C-09 should complete this questionnaire at: (1) baseline (after consent and prior to randomization) and (2) 4-6 weeks after surgery
- StudyEvent: NSABP Protocol C-09: Quality of Life Form